A stripped-down version of the US Food and Drug Administration user-fee reauthorization package, introduced in the Senate on 14 July, leaves out provisions for modernizing cosmetics oversight and strengthening dietary supplement regulations.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?